KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash & Equivalents (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Cash & Equivalents data on record, last reported at $180.1 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 37.53% year-over-year to $180.1 million; the TTM value through Dec 2025 reached $180.1 million, down 37.53%, while the annual FY2025 figure was $180.1 million, 37.53% down from the prior year.
  • Cash & Equivalents reached $180.1 million in Q4 2025 per IDXX's latest filing, down from $208.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $453.9 million in Q4 2023 and bottomed at $99.2 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $227.3 million, with a median of $192.3 million recorded in 2022.
  • The widest YoY moves for Cash & Equivalents: up 331.43% in 2021, down 62.37% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $144.5 million in 2021, then dropped by 22.09% to $112.5 million in 2022, then surged by 303.33% to $453.9 million in 2023, then plummeted by 36.5% to $288.3 million in 2024, then plummeted by 37.53% to $180.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $180.1 million in Q4 2025, $208.2 million in Q3 2025, and $164.6 million in Q2 2025.